Literature DB >> 12734920

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.

George Wells1, Jennifer Anderson, Maarten Boers, David Felson, Turid Heiberg, Sarah Hewlett, Kent Johnson, John Kirwan, Marissa Lassere, Vivian Robinson, Beverley Shea, Lee Simon, Vibeke Strand, Piet van Riel, Peter Tugwell.   

Abstract

The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.

Entities:  

Mesh：

Year:  2003        PMID： 12734920

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  7 in total

1.  Patient-level minimal clinically important difference based on clinical judgment and minimally detectable measurement difference: a rationale for the SF-36 physical function scale in the SPORT intervertebral disc herniation cohort.

Authors:  Kevin F Spratt
Journal:  Spine (Phila Pa 1976)       Date:  2009-07-15       Impact factor: 3.468

2.  The lack of association between changes in functional outcomes and work retention in a chronic disabling occupational spinal disorder population: implications for the minimum clinical important difference.

Authors:  Hilary D Wilson; Tom G Mayer; Robert J Gatchel
Journal:  Spine (Phila Pa 1976)       Date:  2011-03-15       Impact factor: 3.468

3.  Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis.

Authors:  T Heiberg; A Finset; T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2005-02       Impact factor: 19.103

4.  Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.

Authors:  F Tubach; P Ravaud; G Baron; B Falissard; I Logeart; N Bellamy; C Bombardier; D Felson; M Hochberg; D van der Heijde; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

Review 5.  Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.

Authors:  Lilian H D van Tuyl; Steven C Vlad; David T Felson; George Wells; Maarten Boers
Journal:  Arthritis Rheum       Date:  2009-05-15

6.  The Assessment of Clinically Significant Differences in Treating Spinal Deformity Using the SRS Questionnaire: What Is the Threshold of Change That Is Meaningful to Patients?

Authors:  Sigurd Berven; Matthew Baron; Vedat Deviren; Steven Glassman; Keith Bridwell; Kushagra Verma
Journal:  Int J Spine Surg       Date:  2019-04-30

Review 7.  Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Authors:  Jenni Hislop; Temitope E Adewuyi; Luke D Vale; Kirsten Harrild; Cynthia Fraser; Tara Gurung; Douglas G Altman; Andrew H Briggs; Peter Fayers; Craig R Ramsay; John D Norrie; Ian M Harvey; Brian Buckley; Jonathan A Cook
Journal:  PLoS Med       Date:  2014-05-13       Impact factor: 11.069
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.